A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer
Clinical trial NCT02178956 · COMPLETED
Trial details
- NCT number
- NCT02178956
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2017-09-20
- Enrollment
- 714
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.